The effectiveness of Apigenin derivatives has been utilized in this current investigation as the proposed compounds for the novel treatments for HPV-associated cervical cancer and the DNA polymerase theta since there is no targeted therapy for them. This evidence concerns the gene POLQ and cervical cancer.